| Literature DB >> 24575415 |
Zerrin Pulathan1, Gökalp Altun1, Doğuş Hemşinli1, Ahmet Menteşe2, Esin Yuluğ3, Ali Civelek1.
Abstract
OBJECTIVE: The purpose of this study is to evaluate the effect of ethyl pyruvate (EP) on systemic inflammatory response and lung injury in an experimental rat model of ruptured abdominal aortic anurysm (RAAA).Entities:
Mesh:
Substances:
Year: 2014 PMID: 24575415 PMCID: PMC3915710 DOI: 10.1155/2014/857109
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Schematic diagram of the interventions in each study group.
| Groups |
| Shock | Treatment | Heparin | (1/2) Blood | Clamp | (1/2) Blood | Reperfusion | Blood and |
|---|---|---|---|---|---|---|---|---|---|
| Sh | 6 | − | RL | + | − | − | − | − | + |
| Sh + EP | 6 | − | 40 mg/kg | + | − | − | − | − | + |
| S/C | 9 | + | RL | + | + | + | + | + | + |
| S/C + EP | 9 | + | 40 mg/kg | + | + | + | + | + | + |
Sh: sham; EP: ethyl pyruvate; S/C: shock/clamp; RL: Ringer's lactate solution.
Biochemical parameters and histopathological scores in all groups (mean ± SD).
| Parameters | Sh ( | Sh + EP ( | S/C ( | S/C + EP ( |
|---|---|---|---|---|
| MPO (ng/mL) | 81.82 ± 34.21 | 96.91 ± 49.32 | 383.85 ± 38.19a,b | 198.33 ± 69.16a,b,c |
| MDA (nmol/mL) | 1.42 ± 0.43 | 1.45 ± 0.34 | 2.95 ± 1.45a,b | 1.96 ± 0.61a,b,c |
| TNF | 151.63 ± 30.64 | 147.52 ± 16.14 | 262.71 ± 18.24a,b | 188.76 ± 56.55a,b,c |
| IL-6 (pg/mL) | 164.62 ± 16.18 | 157.98 ± 19.93 | 196.53 ± 52.22 | 183.98 ± 56.75 |
| IMA (ABSU) | 0.42 ± 0.3 | 0.32 ± 0.21 | 0.84 ± 0.43a,b | 0.74 ± 0.22a,b |
| Lung MDA (nmol/g) | 454.29 ± 35.2 | 461.63 ± 51.26 | 522.5 ± 81.12a,b | 499.14 ± 43.2a,b,c |
| Lung MPO (ng/mL) | 5636.77 ± 404.7 | 5894.49 ± 971.17 | 6541.1 ± 613.4a,b | 6019.12 ± 394.4a,c |
| W/D weight ratio | 2.28 ± 0.18 | 2.21 ± 0.08 | 5.55 ± 0.45a,b | 3.77 ± 0.74a,b,c |
| Histopathological score | 0.5 ± 0.5 | 0.5 ± 0.4 | 2.66 ± 0.7a,b | 1.44 ± 0.72a,b,c |
Note: Sh: sham; EP: ethyl pyruvate; S/C: shock/clamp; MDA: malondialdehyde; MPO: myeloperoxidase; TNFα: tumor necrosis factor alpha; IL-6: interleukin-6; IMA: ischemia modified albumin; W/D ratio: wet/dry ratio.
a P < 0.016 versus Sh.
b P < 0.016 versus Sh + EP.
c P < 0.016 versus S/C.
Blood gas values.
| pH | PO2 | PCO2 | HCO3 | BE | |
|---|---|---|---|---|---|
| Sh | 7.38 ± 0.04 | 115.75 ± 12.34 | 41.8 ± 5.7 | 25.45 ± 1.73 | 0.43 ± 1.38 |
| Sh + EP | 7.44 ± 0.08 | 107.43 ± 9.54 | 34.3 ± 11.6 | 23.51 ± 5.14 | 0.13 ± 2.49 |
| S/C | 7.20 ± 0.09a,b | 79.88 ± 18.39 | 36.1 ± 7.05 | 15.4 ± 4.7 | −9.38 ± 5.04a,b |
| S/C + EP | 7.33 ± 0.07a,b | 87.11 ± 14.29 | 36.9 ± 7.47 | 19.24 ± 2.88 | −5.64 ± 2.8a,b |
PaO2: arterial oxygen pressure; PaCO2: arterial carbon dioxide pressure; HCO3: bicarbonate; BE: base excess.
a P < 0.016 versus Sh.
b P < 0.016 versus Sh + EP.
c P < 0.016 versus S/C.
Figure 1(Sh, Sh + EP) Normal histopathological examination of the lung tissues in Sh and Sh + EP groups. (S/C) Diffuse intra-alveolar edema (↑), intra-alveolar hemorrhage (▲), and leukocyte infiltration in the S/C group. (S/C + EP) Moderate intra-alveolar edema and alveolar epithelial thickening (↑) were observed in the S/C group that received EP. (Hematoxylin and Eosin, [H&E] ×200).
Figure 2Mean arterial blood pressure during the experiment. Values are mean ± SEM.